Skip to main content
. Author manuscript; available in PMC: 2013 Apr 22.
Published in final edited form as: Cancer J. 2012 Jan-Feb;18(1):69–81. doi: 10.1097/PPO.0b013e31824671c9

Figure 1. Timeline of oncolytic virus development from glioblastoma therapy.

Figure 1

This schematic diagram lists viruses with oncolytic potential based on their first description in preclinical glioma studies starting in 1991. Subsequent major developments within one virus group are included. Viruses are color-coded based on their pathogenic background as human pathogen (orange), human vaccine (yellow), or non-human pathogen (blue).